Abstract
A 26-year-old woman presented with general fatigue, persistent fever, nuchal lymphadenitis, thrombocytopenia, and liver damage. From the bone marrow finding, we diagnosed her condition as hemophagocytic syndrome. Steroid pulse therapy, cyclosporin A treatment, and combined chemotherapy generated no response. The patient showed severe mucosal bleeding, rapidly experienced multiple organ failure, and finally died of a brain hemorrhage on the 13th hospital day. Epstein-Barr virus, cytomegalovirus, human herpes virus type 6, human parvovirus B19, and herpes simplex virus were not detected. Autopsied samples of the spleen, bone marrow, and liver showed extreme proliferation of activated macrophages, so-called histiocytes, without lymphoid malignancy. The interferon γ level at presentation was prominently high. The continuously elevated levels of ferritin and soluble interleukin 2 receptor were correlated with the catastrophic outcome. The disease in our case mimicked infantile hemophagocytic lymphohistiocytosis. However, there was neither a family history of the disease nor a mutation in the perforin gene. So, it is reasonable to categorize our case as macrophage activation syndrome. Although our patient lacked arthritis or eruption, we cannot deny the possibility that an oligoarthritis type of systemiconset juvenile rheumatoid arthritis or, considering the patient’s age, adult-onset Still disease lies at the base of our case.
Article PDF
Similar content being viewed by others
References
Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol. 1992;9:63–74.
Tsuda H. Hemophagocytic syndrome in children and adults. Int J Hematol. 1997;65:215–226.
Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979;44:993–1002.
Esumi N, Ikushima S, Todo S, Imashuku S. High serum level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer. 1988;61:2071–2076.
Vespignani S, Sardeo G, Castronovo S, Galassi A, Venza E. A case of virus associated hemophagocytic syndrome and malignant histiocytosis: sometimes a difficult distinction. Recenti Prog Med. 1991;82:80–82.
Lasserre M, Huguet C, Terno O. Acute severe herpes simplex hepatitis with virus-associated hemophagocytic syndrome in an immunocompetent adult. J Hepatol. 1993;18:256–257.
Takeoka Y, Hino M, Oiso N, et al. Virus-associated hemophagocytic syndrome due to rubella virus and varicella-zoster dual infection in patient with adult idiopathic thrombocytopenic purpura. Ann Hematol. 2001;80:361–364.
Tsuda H, Shirono K. Successful treatment of virus-associated hemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br J Haematol. 1996;93:572–575.
Huang LM, Lee CY, Lin KH, et al. Human herpes virus-6 associated with fatal hemophagocytic syndrome. Lancet. 1990;336:60–61.
Levy J, Wodell RA, August CS, Bayever E, et al. Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant. 1990;6:349–352.
Marusawa H, Hamamoto K. Virus-associated hemophagocytic syndrome due to rubella virus in an adult [in Japanese]. Rinsho Ketsueki. 1994;35:576–580.
Kikuta H, Sakiyama Y, Matsumoto S, et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 1993;82:3259–3264.
Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol. 2003;41:103–109.
Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol. 1991;18:29–33.
Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr. 1996;129:630–632.
Marmont AM, Gualandi F, Lint MT, Bacigalupo A. Virus-associated hemophagocytic syndrome: interest of examination of fresh myeloaspirates. Blood. 1994;83:1711–1712.
Ueda I, Morimoto A, Inaba T, et al. Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol. 2003;121:503–510.
Allen M, Fusco CD, Legrand F, et al. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica. 2001;86:499–503.
Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100:2266–2267.
Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemiconset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003;142:292–296.
Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587–590.
Esdaile JM, Tannenbaum H, Hawkins D. Adult Still’s disease. Am J Med. 1980;68:825–830.
Mert A, Ozaras R, Tabak F, et al. Fever of unknown origin: a review of 20 patients with adult-onset Still’s disease. Clin Rheumatol. 2003;22:89–93.
Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology. 4th ed. Philadelphia, Pa: W. B. Saunders; 1997:269.
Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78:2918–2922.
Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulation Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100–4103.
Ohga S, Matsuzaki A, Nishizaki M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome: interferon gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol. 1993;15:291–298.
Imashuku S, Hibi S. Cytokines in hemophagocytic syndrome. Br J Haematol. 1991;77:438–440.
Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still’s disease. J Rheumatol. 2003;30:2422–2427.
Esumi N, Ikushima S, Todo S, Imashuku S. Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis: a survey of pediatric cases. Acta Paediatr Scand. 1989;78:268–270.
Emmenegger U, Frey U, Reimers A, et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol. 2001;68:4–10.
Coffernils M, Soupart A, Pradier O, Feremans W, Neve P, Decaux G. Hyperferritinemia in adult onset Still’s disease and the hemophagocytic syndrome. J Rheumatol. 1992;19:1425–1427.
Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood. 1989;73:2128–2132.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Muta, T., Yamano, Y. Fulminant Hemophagocytic Syndrome with a High Interferon γ Level Diagnosed as Macrophage Activation Syndrome. Int J Hematol 79, 484–487 (2004). https://doi.org/10.1532/IJH97.04008
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.04008